Greylin Investment Mangement Inc Teva Pharmaceutical Industries LTD Transaction History

Greylin Investment Mangement Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 15, 2019	SELL	$8.12 - $15.72 $913,621 - $1.77 Million	-112,515 Closed	0 $0
Q1 2019 Apr 09, 2019	SELL	$15.58 - $20.01 $1.56 Million - $2 Million	-99,940 Reduced 47.04%	112,515 $1.76 Million
Q4 2018 Jan 14, 2019	SELL	$14.59 - $23.84 $356,579 - $582,649	-24,440 Reduced 10.32%	212,455 $3.28 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $107,616 - $131,071	-5,110 Reduced 2.11%	236,895 $5.1 Million
Q2 2018 Aug 07, 2018	SELL	$16.77 - $24.71 $86,365 - $127,256	-5,150 Reduced 2.08%	242,005 $5.89 Million
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $56,545 - $74,817	-3,390 Reduced 1.35%	247,155 $4.22 Million
Q4 2017 Jan 16, 2018	BUY	$11.23 - $19.1 $232,236 - $394,988	20,680 Added 9.0%	250,545 $4.75 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $3.54 Million - $7.39 Million	229,865	229,865 $4.05 Million

629

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

Stay updated on Greylin Investment Mangement Inc with notifications on news.